🔎 Trials Near Me

Akèy › Myelofibroz › Illinois › Chicago

Etid klinik pou Myelofibroz nan Chicago, IL

7 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Ap rekriteFaz 1/2
  • University of Chicago, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04176198

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Ap rekriteFaz 2
  • University of Chicago Comprehensive Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06661915

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • University of Chicago Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07008118

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Ap rekriteFaz 1
  • University of Chicago, Chicago
Laj 13 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT04771572

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Ap rekriteEtid obsèvasyon
  • MPN Research Foundation, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT07362225

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

Ap rekriteFaz 1
  • The University of Chicago, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Dec 29, 2025 · NCT03326310

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Chicago
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Myelofibroz nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.